M&A in biotech and pharma is expected to surge in late 2024 as regulatory uncertainties ease. Discover trends, key players, and areas of high interest.
Biotech/pharma M&A to pick up in 2025 once regulatory uncertainty declines
Saturday, 26 Apr 2025
Exclusive insights, data, and analysis for financial market experts.
Search
Have an existing account?
Sign In
